title: Leprosy at a turning point?
authors.forename: M
authors.initials: M
authors.lastname: Harboe
mesh_terms: D003622:Dapsone / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005002:Ethiopia / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007194:India / Q000453:epidemiology; D007917:Leprostatic Agents / Q000276:immunology / Q000627:therapeutic use*; D007918:Leprosy / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D009166:Mycobacterium leprae / Q000187:drug effects / Q000276:immunology / Q000472:pathogenicity; D015995:Prevalence
chemical_list: D007917:Leprostatic Agents; D003622:Dapsone